At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 50 enrolled
Drug / intervention
Atorvastatin +1 moredrug
Likely dose
Atorvastatin 10 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Atorvastatin Effects On Arterial Stiffness In Hemodialysis Patients
In Brief
A Phase 2 clinical trial evaluating Atorvastatin and Placebo for Arterial Stiffness. Completed, enrolled 50 participants across 1 site.
Detailed Summary
This research aims to assess effects of atorvastatin on arterial stiffness in hemodialysis patients
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsArterial Stiffness
CountriesEgypt
Collaborators--
Timeline
Phase 2CompletedFinished
202120222023202420252026
First PostedJul 2020
Enrollment StartNov 2020
Primary CompletionMay 2021
Study CompletionJul 2021
TodayJul 2026
First PostedJul 15, 2020
Enrollment StartNov 1, 2020
Primary CompletionMay 1, 2021
Study CompletionJul 1, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 6.0 years ago
Interventions
Atorvastatindrug
atorvastatin 10 mg, as one tablet /day for 24 weeks.
Placebodrug
a placebo in the form of multivitamin tablets similar to the experimental drugs with the same regimen (one tablet /day for 24 weeks)